19220

543998

VALIANTLAB

img img img img
No Data Available

VALIANT LABORATORIES LTD Share Price Update

As of the latest trading session, VALIANT LABORATORIES LTD is trading at ₹79.4, down by ₹-0.61 or -0.76% from its previous close. The stock has moved between ₹77.00 and ₹80.02 today. Over the past year, the stock has delivered a return of -14.80%. In the last month, it has returned 5.44%.

VALIANT LABORATORIES LTD performance

Today’s low Today’s high
₹ 77.00 ₹ 80.02
₹ 77.44
52 week low 52 week high
₹ 49.51 ₹ 115.54
₹ 77.44
Open Price ₹ 80.02
Prev. Close ₹ 80.02
Volume (Shares) 18713.00
Total traded value ₹ 14.49
Upper Circuit ₹ 84.02
Lower Circuit ₹ 76.02
info

Investment Returns

Over 1 Month 5.44% Over 3 Months 39.69% Over 6 Months 18.00% Over 1 Year -14.80%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

VALIANT LABORATORIES LTD fundamentals


  • Market cap (Cr) 420.60
  • P/E Ratio (TTM) 75.98
  • Beta 0.92
  • Book Value / share 58.87
  • Return on equity -1.40%
  • EPS (TTM) 1.02
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 3.53
info icon alternate text
  • Market cap (Cr) 424.20
  • P/E Ratio (TTM) 75.98
  • Beta 0.90
  • Book Value / share 58.87
  • Return on equity -1.40%
  • EPS (TTM) 1.02
  • Dividend yield 0.00%
  • Net profit/quarter (Cr) 3.53
info icon alternate text

VALIANT LABORATORIES LTD Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 65.30
Operating Expense 61.34
Net Profit 3.53
Net Profit Margin (%) 5.40
Earnings Per Share (EPS) 0.65
EBITDA 5.27
Effective Tax Rate (%) 25.36
Particulars DEC 2025 (Values in Cr)
Revenue 54.74
Operating Expense 55.24
Net Profit 0.03
Net Profit Margin (%) 0.05
Earnings Per Share (EPS) 0.01
EBITDA 0.86
Effective Tax Rate (%) 72.72
Particulars SEP 2025 (Values in Cr)
Revenue 45.99
Operating Expense 46.58
Net Profit 0.17
Net Profit Margin (%) 0.36
Earnings Per Share (EPS) 0.03
EBITDA 0.91
Effective Tax Rate (%) 34.61
Particulars JUN 2025 (Values in Cr)
Revenue 51.01
Operating Expense 49.23
Net Profit 1.82
Net Profit Margin (%) 3.56
Earnings Per Share (EPS) 0.42
EBITDA 3.03
Effective Tax Rate (%) 25.71
Particulars MAR 2025 (Values in Cr)
Revenue 57.77
Operating Expense 54.50
Net Profit 3.24
Net Profit Margin (%) 5.60
Earnings Per Share (EPS) 0.74
EBITDA 4.47
Effective Tax Rate (%) 17.60
Particulars MAR 2026 (Values in Cr)
Revenue 217.04
Operating Expense 212.39
Net Profit 5.55
Net Profit Margin (%) 2.55
Earnings Per Share (EPS) 1.02
EBITDA 10.07
Effective Tax Rate (%) 26.49
Particulars MAR 2025 (Values in Cr)
Revenue 133.36
Operating Expense 140.24
Net Profit -2.15
Net Profit Margin (%) -1.61
Earnings Per Share (EPS) -0.50
EBITDA 0.75
Effective Tax Rate (%) -48.27
Particulars MAR 2024 (Values in Cr)
Revenue 182.05
Operating Expense 192.49
Net Profit 0.34
Net Profit Margin (%) 0.18
Earnings Per Share (EPS) 0.14
EBITDA 1.27
Effective Tax Rate (%) 145.33
Particulars MAR 2023 (Values in Cr)
Revenue 333.91
Operating Expense 300.63
Net Profit 29.00
Net Profit Margin (%) 8.68
Earnings Per Share (EPS) 8.91
EBITDA 39.95
Effective Tax Rate (%) 23.96
Particulars MAR 2022 (Values in Cr)
Revenue 291.52
Operating Expense 251.76
Net Profit 27.50
Net Profit Margin (%) 9.43
Earnings Per Share (EPS) 16.99
EBITDA 44.26
Effective Tax Rate (%) 34.07
Particulars MAR 2025 (Values in Cr)
Book Value / Share 53.93
ROE % -1.43
ROCE % -0.95
Total Debt to Total Equity 0.42
EBITDA Margin -0.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.51
ROE % -1.71
ROCE % -1.63
Total Debt to Total Equity 0.41
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 28.86
ROCE % 23.73
Total Debt to Total Equity 0.60
EBITDA Margin 11.96
Particulars MAR 2025 (Values in Cr)
Book Value / Share 53.94
ROE % -1.40
ROCE % -1.05
Total Debt to Total Equity 0.25
EBITDA Margin -0.82
Particulars MAR 2024 (Values in Cr)
Book Value / Share 54.52
ROE % -1.70
ROCE % -1.68
Total Debt to Total Equity 0.36
EBITDA Margin -1.05
Particulars MAR 2023 (Values in Cr)
Book Value / Share 30.86
ROE % 33.73
ROCE % 26.00
Total Debt to Total Equity 0.71
EBITDA Margin 11.96
Particulars MAR 2022 (Values in Cr)
Book Value / Share 43.89
ROE % 34.37
ROCE % 37.35
Total Debt to Total Equity 0.39
EBITDA Margin 15.18
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.36
ROE % 34.53
ROCE % 54.13
Total Debt to Total Equity 0.01
EBITDA Margin 28.19
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 75.99
Total Assets 400.85
Total Liabilities 400.85
Total Equity 234.31
Share Outstanding 4
Price to Book Ratio 1.42
Return on Assets (%) -0.54
Return on Capital (%) -0.62
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 106.21
Total Assets 342.68
Total Liabilities 342.68
Total Equity 236.86
Share Outstanding 4
Price to Book Ratio 2.67
Return on Assets (%) 0.09
Return on Capital (%) 0.1
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.34
Total Assets 212.96
Total Liabilities 212.96
Total Equity 100.49
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) 13.61
Return on Capital (%) 18.14
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 27.33
Total Assets 317.28
Total Liabilities 317.28
Total Equity 234.38
Share Outstanding 4
Price to Book Ratio 1.42
Return on Assets (%) -0.67
Return on Capital (%) -0.73
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 96.72
Total Assets 324.72
Total Liabilities 324.72
Total Equity 236.88
Share Outstanding 4
Price to Book Ratio 2.67
Return on Assets (%) 0.10
Return on Capital (%) 0.11
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.45
Total Assets 212.75
Total Liabilities 212.75
Total Equity 100.49
Share Outstanding 3
Price to Book Ratio 0.00
Return on Assets (%) 13.62
Return on Capital (%) 18.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 20.13
Total Assets 181.81
Total Liabilities 181.81
Total Equity 71.46
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 15.12
Return on Capital (%) 20.81
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.93
Total Assets 106.31
Total Liabilities 106.31
Total Equity 88.58
Share Outstanding 1
Price to Book Ratio 0.00
Return on Assets (%) 28.77
Return on Capital (%) 34.4
Particulars MAR 2025 (Values in Cr)
Net Income -1.51
Cash from Operations -1.15
Cash from Investing -52.76
Cash from Financing 44.65
Net change in Cash -6.80
Free Cash Flow 112.70
Particulars MAR 2024 (Values in Cr)
Net Income -0.76
Cash from Operations 0.90
Cash from Investing -143.87
Cash from Financing 152.44
Net change in Cash 10.45
Free Cash Flow 46.77
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 64.85
Cash from Investing -55.16
Cash from Financing -0.93
Net change in Cash -0.05
Free Cash Flow 102.53
Particulars MAR 2025 (Values in Cr)
Net Income -1.44
Cash from Operations -25.08
Cash from Investing 24.97
Cash from Financing -0.50
Net change in Cash 2.57
Free Cash Flow -24.52
Particulars MAR 2024 (Values in Cr)
Net Income -0.75
Cash from Operations 47.80
Cash from Investing -182.72
Cash from Financing 135.79
Net change in Cash 1.85
Free Cash Flow 51.55
Particulars MAR 2023 (Values in Cr)
Net Income 38.13
Cash from Operations 31.75
Cash from Investing -21.17
Cash from Financing -1.53
Net change in Cash 0.24
Free Cash Flow 38.82
Particulars MAR 2022 (Values in Cr)
Net Income 41.70
Cash from Operations 16.71
Cash from Investing -12.23
Cash from Financing 6.18
Net change in Cash -3.80
Free Cash Flow 23.59
Particulars MAR 2021 (Values in Cr)
Net Income 47.02
Cash from Operations 25.56
Cash from Investing -16.66
Cash from Financing 11.42
Net change in Cash 3.86
Free Cash Flow 27.23
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 14.41 1.68 267.30 23.12 40.00
BLISS GVS PHARMA LTD. 396.35 32.07 3.51 4192.95 118.35 399.00
CIPLA LTD 1418.20 28.08 3.32 114562.27 1165.55 1672.20
FERMENTA BIOTECH LIMITED 293.20 12.93 2.12 862.92 256.40 399.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.88 24.39 4.49 267.30 23.12 40.00
AMRUTANJAN HEALTH CARE LTD. 559.20 25.06 4.36 1616.68 490.00 789.95
ASTRAZENECA PHARMA IND LT 8655.30 104.02 27.08 21638.25 7630.00 10653.05
BLISS GVS PHARMA LTD. 396.35 42.62 3.62 4192.95 118.35 399.00

VALIANT LABORATORIES LTD shareholding pattern

Holding
24.86%
74.93%
0.19%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

News

Left Arrow
Right Arrow

VALIANT LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
77.44 -3.22 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 78.40
  • 26 Days 75.10
  • 10 Days 77.80
  • 50 Days 71.10
  • 12 Days 77.60
  • 100 Days 69.20
  • 20 Days 76.40
  • 200 Days 73.80
79.97 PIVOT
First Support 78.05 First Resistance 81.95 Second Support 76.07 Second Resistance 83.87 Third Support 74.15 Third Resistance 85.85
RSI 64.04 ADX 38.65 MACD 2.48 Williams % R -23.70 Commodity Channel Index (CCI) 94.84
Date [-] Week 0.0 Same Day 0.0 Month 0.0
1 Year 0.92 3 Year 1.02
Over 1 Month
5.44% down
Over 1 Year
-14.80% down
Over 3 Months
39.69% down
Over 3 Years
-20.30% down
Over 6 Months
18.00% down
Over 5 Years
0.00% down

VALIANT LABORATORIES LTD Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Valiant Laboratories Ltd?

Answer Field

Valiant Laboratories Ltd share price is for NSE ₹ 79.40 & for BSE ₹ 78.10 as on May 29 2026 03:19 PM.

What is the Market Cap of Valiant Laboratories Ltd Share?

Answer Field

The market cap of Valiant Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 29 2026 03:19 PM.

What is the 52 Week High and Low of Valiant Laboratories Ltd?

Answer Field

The 52 Week High and Low of Valiant Laboratories Ltd for NSE is ₹ 115.54 and ₹ 49.51 and for BSE is ₹ 114.72 and ₹ 50.00.

What is 1 year return for Valiant Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -14.80%.

What is the P/E Ratio of Valiant Laboratories Ltd Share?

Answer Field

As on May 29 2026 03:19 PM the price-to-earnings (PE) ratio for Valiant Laboratories Ltd share is 75.98.

What is the PB ratio of Valiant Laboratories Ltd Share?

Answer Field

As on May 29 2026 03:19 PM, the price-to-book (PB) ratio for Valiant Laboratories Ltd share is 58.87.

How to Buy Valiant Laboratories Ltd Share?

Answer Field

You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Valiant Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Valiant Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Valiant Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|